azedra | FDA approves first treatment for rare adrenal tumors

Keyword	CPC	PCC	Volume	Score	Length of keyword
azedra	0.36	0.8	2233	14	6

Keyword	CPC	PCC	Volume	Score
azedra	1.92	0.1	945	52
azedra treatment	1.5	0.3	1453	24
azedra i 131	0.19	0.3	546	15
azedra discontinued	1.36	0.1	2233	33
azedra package insert	0.19	0.5	631	73
azedra sales	1.3	0.1	6907	83
azedra therapy	0.64	0.4	1771	74
azedra iobenguane i 131	0.52	0.2	6497	28
azedra fda approval	0.28	0.9	7661	86
azedra drug	1.87	0.1	800	77
azedra cost	0.2	1	5818	7
azedra prescribing information	1.47	0.5	6879	24
azedra pi	1.37	1	982	78

Search Results related to azedra on Search Engine

FDA approves first treatment for rare adrenal tumors | FDA
fda.gov

https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-rare-adrenal-tumors

WEBThe U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the...

DA: 64 PA: 19 MOZ Rank: 94

Azedra Uses, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/mtm/azedra.html

WEBNov 10, 2023 · What is Azedra? Azedra is a radiopharmaceutical (RAY dee oh far ma SOO tik al) medicine that is used to treat a certain type of adrenal gland tumor (pheochromocytoma). Azedra is also used to treat a rare type of nerve cell tumor (paraganglioma) that can spread throughout the body.

DA: 89 PA: 13 MOZ Rank: 38

FDA approves iobenguane I 131 for rare adrenal gland tumors
fda.gov

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-iobenguane-i-131-rare-adrenal-gland-tumors

WEBOn July 30, 2018, the Food and Drug Administration approved iobenguane I 131 (AZEDRA, Progenics Pharmaceuticals, Inc.) for adult and pediatric patients (12 years and older) with iobenguane...

DA: 78 PA: 51 MOZ Rank: 34

HIGHLIGHTS OF PRESCRIBING INFORMATION …
fda.gov

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209607s000lbl.pdf

WEBAZEDRA is a radioactive therapeutic agent indicated for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive, unresectable, locally advanced or...

DA: 55 PA: 23 MOZ Rank: 51

First FDA-approved treatment for an ultra-rare disease - Nature
nature.com

https://www.nature.com/articles/d42473-019-00193-6

WEBAZEDRA is indicated for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive, unresectable, locally advanced or metastatic pheochromocytoma or ...

DA: 86 PA: 92 MOZ Rank: 93

Azedra (iobenguane I 131) in patients with malignant, recurrent …
ascopubs.org

https://ascopubs.org/doi/10.1200/JCO.2018.36.15_suppl.4005

WEBJun 1, 2018 · Azedra (iobenguane I 131) in patients with malignant, recurrent and/or unresectable pheochromocytoma or paraganglioma (PPGL): Updated efficacy and safety results from a multi-center, open-label, pivotal phase 2 study. | Journal of Clinical Oncology.

DA: 92 PA: 98 MOZ Rank: 78

Penn-led Trial Shows AZEDRA Can Be Effective, Safe for …
pennmedicine.org

https://www.pennmedicine.org/news/news-releases/2018/may/penn-led-trial-shows-azedra-can-be-effective-safe-for-treatment-of-rare-neuroendocrine-tumors

WEBAZEDRA is a radiotherapy drug that attacks these tumors with a high, specifically-targeted dose. The FDA gave it an Orphan Drug designation, Fast Track status, and Breakthrough Therapy designation in the U.S. In the Penn-led trial, 68 patients received at least one therapeutic dose of AZEDRA.

DA: 12 PA: 73 MOZ Rank: 74

Therapy for Rare Cancers Receives FDA Approval Following Trials …
pennmedicine.org

https://www.pennmedicine.org/news/news-releases/2018/july/azedra-fda-approval

WEBJul 31, 2018 · AZEDRA is a radiotherapy drug that attacks these tumors with a high, specifically-targeted dose. The FDA gave it an Orphan Drug designation, Fast Track status, and Breakthrough Therapy designation in the U.S. In the Penn-led trial, 68 patients received at least one therapeutic dose of AZEDRA.

DA: 85 PA: 21 MOZ Rank: 21

Azedra Therapeutic Vial - Uses, Side Effects, and More - WebMD
webmd.com

https://www.webmd.com/drugs/2/drug-175959/azedra-therapeutic-intravenous/details

WEBThis medication is used to treat certain cancers ( pheochromocytoma, paraganglioma). Iobenguane I 131 is a radioactive drug. It works by building up in certain cancer cells and causing them to die....

DA: 32 PA: 38 MOZ Rank: 85

An update on overall survival from a multi-center, open-label, …
snmjournals.org

https://jnm.snmjournals.org/content/60/supplement_1/564

WEBMay 1, 2019 · Background: AZEDRA, a high-specific-activity iodine-131 meta-iodobenzylguanidine (HSA I-131 MIBG), is indicated for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive, unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (PPGL) who require systemic …

DA: 43 PA: 76 MOZ Rank: 100